순천향대학교 부속 서울병원은 서울특별시 용산구 대사관로 59에 있는 순천향대학교 산하의 종합병원이다.

During the past decade, Soonchunhyang University Hospital conducted 60 clinical trials. In the 10-year time frame, 60 clinical trials started and 9 clinical trials were completed, i.e. on average, 15% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 6 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Soonchunhyang University Hospital" #1 sponsor was "Soonchunhyang University Hospital" with 11 trials, followed by "Seoul National University Hospital" with 6 trials sponsored, "Chong Kun Dang Pharmaceutical" with 5 trials sponsored, "Samsung Medical Center" with 5 trials sponsored and "Boehringer Ingelheim" with 5 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 49 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Soonchunhyang University Hospital" #1 collaborator was "Asan Medical Center" with 7 trials as a collaborator, "Soonchunhyang University Hospital" with 7 trials as a collaborator, "Seoul National University Hospital" with 6 trials as a collaborator, "Inje University" with 5 trials as a collaborator and "Keimyung University Dongsan Medical Center" with 5 trials as a collaborator. Other collaborators include 107 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "Soonchunhyang University Hospital" are "Coronary Artery Disease" (5 trials), "Hepatocellular Carcinoma" (5 trials), "Idiopathic Pulmonary Fibrosis" (5 trials), "Essential Hypertension" (3 trials) and "Hypertension" (3 trials). Many other conditions were trialed in "Soonchunhyang University Hospital" in a lesser frequency.

Most popular intervention types in "Soonchunhyang University Hospital" are "Drug" (58 trials), "Biological" (9 trials), "Device" (8 trials), "Procedure" (8 trials) and "Other" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Aspirin" (3 trials), "Cilostazol" (3 trials), "Amlodipine 10mg, Candesartan cilexetil 16mg" (2 trials) and "Amlodipine 5mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Soonchunhyang University Hospital" are 90 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Soonchunhyang University Hospital". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 48 completed trials in Soonchunhyang University Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Soonchunhyang University Hospital, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 7 trials that are defined as “Not Applicable".